Latest Period
Q1 2026
CUSIP: 80880W205
Latest Period
Q1 2026
Institutions Reporting
66
Shares (Excl. Options)
871,688
Price
$6.66
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
Latest holder context comes from 66 institutions filings for Q1 2026.
What is CUSIP 80880W205?
CUSIP 80880W205 identifies SCLX - Scilex Holding Co - Common Stock, par value $0.0001 per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q1 2026 holders report and the ownership history table below.
Use the next link that matches the question you still need to answer about this security.
Open recent reporting periods for CUSIP 80880W205:
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 8.6% | $31,008,000 | 4,800,000 | Armistice Capital, LLC | 30 Jun 2025 | |||
| ORAMED PHARMACEUTICALS INC. | 4.9% | -50% | $5,438,249 | -$4,921,820 | 437,510 | -48% | Oramed Pharmaceuticals Inc. | 31 Dec 2025 |
As of 31 Mar 2026, 66 institutional investors reported holding 871,688 shares of Scilex Holding Co - Common Stock, par value $0.0001 per share (SCLX). This represents 9.8% of the company’s total 8,928,776 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 871,688 | $5,805,688 | -$2,086,248 | $6.66 | 66 |
| 2025 Q4 | 1,119,739 | $13,661,197 | +$3,630,948 | $12.20 | 78 |
| 2025 Q3 | 759,753 | $14,960,373 | +$3,238,244 | $19.68 | 79 |
| 2025 Q2 | 619,696 | $3,649,745 | +$3,564,555 | $5.89 | 63 |
| 2025 Q1 | 42,004 | $10,442 | +$10,434 | $0.25 | 4 |
| 2024 Q4 | 19 | $8 | $0.42 | 1 | |
| 2024 Q3 | 19 | $18 | $0.95 | 1 | |
| 2024 Q2 | 19 | $37 | +$37 | $1.95 | 1 |